Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Total 13F shares
-
25,771,799
-
Share change
-
+4,983,023
-
Total reported value
-
$1,136,970,052
-
Price per share
-
$44.12
-
Number of holders
-
112
-
Value change
-
+$216,275,676
-
Number of buys
-
82
-
Number of sells
-
50
Institutional Holders of Pulmonx Corp - COM (LUNG) as of Q2 2021
As of 30 Jun 2021,
Pulmonx Corp - COM (LUNG) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,771,799 shares.
The largest 10 holders included
Capital World Investors, BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), RTW INVESTMENTS, LP, Champlain Investment Partners, LLC, GILDER GAGNON HOWE & CO LLC, KPCB XIII Associates, LLC, and Point72 Asset Management, L.P..
This page lists
112
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.